May 11, 2018 / 11:08 AM / 6 months ago

BRIEF-Trillium Therapeutics Reports Qtrly Earnings Per Share Of $0.65

May 11 (Reuters) - Trillium Therapeutics Inc:

* TRILLIUM THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS

* TRILLIUM THERAPEUTICS INC - QTRLY EARNINGS PER SHARE $0.65

* TRILLIUM THERAPEUTICS INC - EXPECT TO ENROLL FIRST PATIENT IN A PHASE 1 CLINICAL TRIAL OF TTI-622 IN Q2 2018

* TRILLIUM - AS OF MARCH 31, 2018, HAD CASH & CASH EQUIVALENTS & MARKETABLE SECURITIES, & WORKING CAPITAL OF $73.9 MILLION AND $61.7 MILLION, RESPECTIVELY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below